- Report
- June 2025
- 50 Pages
Global
From €2394EUR$2,650USD£2,047GBP
- Report
- June 2025
- 50 Pages
Global
From €2394EUR$2,650USD£2,047GBP
- Report
- June 2025
- 35 Pages
Europe
From €1717EUR$1,900USD£1,468GBP
- Report
- June 2025
- 30 Pages
Europe
From €1717EUR$1,900USD£1,468GBP
- Report
- June 2025
- 20 Pages
Europe
From €1717EUR$1,900USD£1,468GBP
- Report
- March 2024
- 132 Pages
Global
From €858EUR$950USD£734GBP
- Report
- October 2024
Global
From €3162EUR$3,500USD£2,704GBP
- Report
- March 2022
Japan, United States, ... Japan, United States, Europe
From €1310EUR$1,450USD£1,120GBP
- Report
- January 2025
- 132 Pages
Global
From €858EUR$950USD£734GBP
- Report
- April 2024
- 132 Pages
Global
From €858EUR$950USD£734GBP
- Report
- May 2025
- 37 Pages
Australia
From €723EUR$800USD£618GBP
- SWOT Analysis
- April 2025
Global
From €858EUR$950USD£734GBP
- Report
- April 2025
- 41 Pages
United States
- Report
- April 2025
- 28 Pages
Brazil
From €995EUR$1,180USD£880GBP
- Webinar
- March 2025
- 90 Minutes
Global
- Report
- January 2025
- 31 Pages
South Africa
From €1700EUR$2,015USD£1,504GBP
- Report
- January 2025
- 27 Pages
Israel
From €1700EUR$2,015USD£1,504GBP
- Report
- January 2025
- 132 Pages
Global
From €858EUR$950USD£734GBP
- Report
- January 2025
- 132 Pages
Global
From €858EUR$950USD£734GBP

The Analgesics market is a sector of the pharmaceutical industry that focuses on the production and sale of drugs used to relieve pain. Analgesics are used to treat a variety of conditions, including headaches, muscle pain, arthritis, and post-operative pain. Common analgesics include non-steroidal anti-inflammatory drugs (NSAIDs), opioids, and acetaminophen.
Analgesics are available in a variety of forms, including tablets, capsules, liquids, and topical creams. Many analgesics are available over-the-counter, while others require a prescription.
The analgesics market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the analgesics market include Pfizer, Johnson & Johnson, GlaxoSmithKline, Novartis, and Merck. Show Less Read more